Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway

Background: Despite great advances in the diagnosis and treatment of non-small cell lung cancer (NSCLC), early diagnosis remains a challenge because patients usually have advanced lung cancer at the time they are diagnosed. The limited efficacy of conventional chemotherapy is another major problem i...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ma-Sha, Liu, Jun-Yan, Xia, Xiao-Bo, Liu, Ying-Zi, Li, Xi, Yin, Ji-Ye, Peng, Jing-Bo, Wu, Lin, Zhang, Wei, Zhou, Hong-Hao, Liu, Zhao-Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582772/
https://www.ncbi.nlm.nih.gov/pubmed/31249811
http://dx.doi.org/10.3389/fonc.2019.00508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582772/
https://www.ncbi.nlm.nih.gov/pubmed/31249811
http://dx.doi.org/10.3389/fonc.2019.00508

Ejemplares similares